Atlas Trials

Heterogeneity of Metastatic Neuroendocrine Tumors as Determined With 18F-dihydroxyphenylalanine-PET /CT, a Retrospective Analysis

Clinical trial NCT02646644 · COMPLETED

Trial details

NCT number
NCT02646644
Sponsor
University Medical Center Groningen
Status
COMPLETED
Study type
OBSERVATIONAL
Neuroendocrine Tumors
Start date
2016-01-01
Primary completion
2017-05-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.